ACUMEN PHARMACEUTICALS INC (ABOS)
US00509G2093 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -55.93M | -52.37M | -42.86M | -100.61M | -7.33M | |||
| Depreciation Amortization | 67.00K | 61.00K | 30.00K | 0.00 | N/A | |||
| Change In Working Capital | -221.00K | 3.87M | 3.99M | 300.00K | 310.00K | |||
| Interest Paid | N/A | 169.00K | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 5.36M | 5.38M | 3.69M | 82.34M | -430.00K | |||
| OPERATING CASH FLOW | -50.74M | -43.06M | -35.15M | -17.96M | -7.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.00K | -21.00K | -160.00K | -40.00K | N/A | |||
| Other Investing Activity | -138.91M | -171.65M | 39.35M | -104.08M | N/A | |||
| INVESTING CASH FLOW | -138.94M | -171.67M | 39.19M | -104.12M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 30.00M | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 122.23M | 3.91M | 200.47M | 44.68M | |||
| Other Financing Activity | N/A | -476.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 151.75M | 3.91M | 200.47M | 44.68M | |||
| CHANGE IN CASH | -30.84M | -62.98M | 7.95M | 78.39M | 37.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -50.74M | -43.06M | -35.15M | -17.96M | -7.45M | |||
| Capital Expenditure | -32.00K | -21.00K | -160.00K | -40.00K | N/A | |||
| FREE CASH FLOW | -50.77M | -43.09M | -35.31M | -18.00M | -7.45M | |||
All data in USD